期刊文献+

影响老年胰腺癌预后的多因素分析 被引量:2

Multple Factors Analysis of Elderly Patients with Pancreatic Carcinomas
下载PDF
导出
摘要 目的:探讨影响老年胰腺癌预后的因素。方法:回顾分析天津市肿瘤医院2004年1月—2012年12月收治的老年胰腺癌病例(年龄≥65岁)121例,随访至2013年1月者121例。应用Kaplan-Meier法计算生存率,生存曲线采用Log-rank检验,多因素分析采用COX比例风险模型。结果:121例患者生存期为1~19个月,中位生存期(6.0±2.3)个月,其中6个月、12个月、18个月生存率分别为51.2%、13.3%、4.1%。多因素分析显示,手术方式、化疗、对症支持治疗是影响胰腺癌预后的独立因素。结论:老年胰腺癌患者由于对手术、放化疗耐受能力差,往往由于各种原因不能进行常规的治疗,所以应根据老年人个体条件的不同行个体化治疗。最终目的是在尽可能根治的前提下,延长生存时间,提高生活质量。 ObjectiveTo explore the major prognostic factors in old patients with pancreatic carcinoma.MethodsOne hundred and twenty-one patients with pancreatic carcinoma from 2004 to 2012 choosed fromTianjin Medical University Cancer Hospital were reviewed. Survival rate was caculated by Kaplan-Meier estima-tion while survival curve was analysed by log-rank test. Prognostic factors were studied by multivariate analysiswith COX proportional hazards survival model.ResultsIn this group, the survival time was 1 to 19 monthsand the median survival time was(6.0 ±2.3) months. The overall survival rates at 6 months, 12 months, 18 months were 51.2%, 13.3%, and 4.1% respectively. Multivariate analysis revealed that independent prognosticfactors were TNM tumor staging, sugical mode, chemotherapy, symptomatic and supportive therapy.Conclusion Elderly patients with pancreatic cancers always have poor ability for tolerance with surgery, radiation and che-motherapy. Becasuse of various reasons, they were not suitable to conventional treatment. They should be individ-ually treated according to the conditions of the elderly individual. The ultimate aim was to offer a radical cure asmuch as possible under the premise of prolonging the survival time and improving the quality of life.
作者 魏志旺 李强
出处 《中国中西医结合外科杂志》 CAS 2016年第5期419-423,共5页 Chinese Journal of Surgery of Integrated Traditional and Western Medicine
关键词 老年胰腺癌 COX比例风险模型 预后 Elderly patients with pancreatic carcinoma COX proportional hazards survival model prognosis
  • 相关文献

参考文献16

  • 1Kim R, Saif MW. Is there an optimal neoadjuvant therapy for local?ly advanced pancreatic cancer [J]? JOP,2007,8(3):279-288.
  • 2Riall TS, Lillemoe KD. Underutilization of surgical resection in pa?tients with localized pancreatic cancer[J]. Ann Surg, 2007,246(2):181-182.
  • 3张群华,倪泉兴,代表中国抗癌协会胰腺癌专业委员会.胰腺癌2340例临床病例分析[J].中华医学杂志,2004,84(3):214-218. 被引量:141
  • 4郑树国,何振平,别平,李智华,马宽生.胰头癌手术范围对预后的影响[J].肝胆胰外科杂志,2000,12(3):127-129. 被引量:3
  • 5胡虞乾,王福顺.胰腺癌治疗方案的实施与胰腺癌分期的关系[J].医学综述,2005,11(4):340-342. 被引量:1
  • 6李强,李慧锴.肠系膜上静脉/门静脉切除在胰腺癌根治切除中的临床价值探讨[J].中华普外科手术学杂志(电子版),2009,3(1):48-50. 被引量:2
  • 7Martignoni ME,Wagner M,Krahenbuhl L,et al. Effect of preopera?tive biliary drainage on surgical outcome after pancreatoduodenec?tomy [J]. Am J Surg ,2001. 181(1):52-59.
  • 8Wagner M,Redaelli C,Lietz M,et al.Curative resection is the sin?gle most important factor determining outcome in patients with pan?creatic adenocarcinoma[J]. Br J Surg,2004,91(5):586-594.
  • 9Conlon KC,Klimstra DS,Brennan MF. Long-term survival aftercurative resection for pancreatic ductal adenocarcinoma. Clinico?pathologic analysis of 5-year survivors[J]. Ann Surg,1996,223( 3):273-279.
  • 10Zinser JW,Hortobagyi GN,Buzdar AU,et al. Clinical course ofbreast carcinoma[J]. Clin Qncol,1987,5(5):773-782.

二级参考文献41

  • 1吴本俨,朱鸣,蔡昌豪,宫桂花,王孟薇,邵勇,徐世平,董为民.老年胰腺癌临床诊治分析[J].军医进修学院学报,2004,25(4):307-308. 被引量:6
  • 2王俊杰,白静,修典荣,冉维强,朱丽红,刘江平.放射性^(125)I粒子组织间植入治疗胰腺癌的疗效[J].中华普通外科杂志,2004,19(8):512-512. 被引量:15
  • 3钟守先.胰头癌根治术的切除范围及注意事项[J].中国实用外科杂志,1995,15(4):206-208. 被引量:16
  • 4何振平,李智华,别平,孙文兵,马宽生.胰腺癌的外科治疗(附80例报告)[J].中国实用外科杂志,1995,15(4):216-217. 被引量:8
  • 5Michaud DS. Epidemiology of pancreatic cancer [ J ] . Minerva Chir, 2004, 59 : 99-111.
  • 6Schneider G, Siveke JT, Eckel F, et al. Pancreatic cancer : basic and clinical aspects [ J ] . Gastroenterology, 2005, 128 : 1606-1625.
  • 7Regine WF, Winter KW, Abrans R, et al. RTOG 9704 a phase III study of adjuvant pre and post chemoradiation ( CRT ) 5-FU vs.gemcitabine ( G ) for resected pancreatic adenocarcinoma [ J ] . J Clin Oncol, 2006, 24 : 4007.
  • 8Kindler HL. Pancreatic cancer : an update [ J ] . Curr Oncol Rep, 2007, 9 : 170-176.
  • 9Homma H, Doi T, Mezawa S, et al. A noval arterial infusion chemotherapy for the treatment of patients with advanced pancreatic cancer after vascular supply distribution via superselective embolization[J]. Cancer, 2000,89(2):303-313.
  • 10Klinkernbij JH, Jeckel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-flurouracil after curative resection of pancreas and periampullary cancer[J]. Ann Surg, 1999, 230(6):776.

共引文献143

同被引文献17

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部